STERIS launches new version of low-temperature sterilization system

STERIS (NYSE:STE) has a launched an enhanced version of a low-temperature sterilization system for surgical instruments.

The Mentor, Ohio, company received 510(k) clearance from the U.S. Food and Drug Administration in September for its new Amsco V-PRO maX Low Temperature Sterilization System.

The system offers three processing cycles to better accommodate a wide variety of surgical instruments, such as flexible endoscopes, cameras, batteries and cannulas, according to a statement from STERIS.

The system uses a 59 percent concentration of hydrogen peroxide to perform sterilization, which helps better prevent damage to instruments compared with sterilizers that use a higher concentration of the substance.

Advertisement

“The V-PRO maX benefits include potential gains in loading, processing and scheduling versatility, improved workflow speed and efficiency, and precedent-setting low-temperature sterile processing productivity,” said Renee Brown, product manager for the company’s infection prevention technologies division.

STERIS’ shares fell about 5 percent yesterday on heavy volume after the company announced that its second-quarter profits had fallen 17 percent.

Brandon Glenn

Brandon Glenn MedCity News

Brandon Glenn is the Ohio bureau chief for MedCity News.

more

Comments RSS Post a comment

No comments yet.

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics